Genetic testing for lymphedema in RASopathies
Variants affecting the function of genes in the RAS–mitogen-activated protein kinase (MAPK) signal transduction pathway have been identified as responsible for a group of developmental syndromes known as RASopathies. Noonan (NS) and cardiofaciocutaneous syndromes (CFC) represent the most frequent an...
Main Authors: | Paolacci Stefano, Rakhmanov Yeltay, Maltese Paolo Enrico, Bruson Alice, Bertelli Matteo |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-09-01
|
Series: | The EuroBiotech Journal |
Subjects: | |
Online Access: | https://doi.org/10.2478/ebtj-2018-0025 |
Similar Items
-
Genetic testing for Hennekam syndrome
by: Rakhmanov Yeltay, et al.
Published: (2018-09-01) -
Genetic testing for Emberger syndrome
by: Rakhmanov Yeltay, et al.
Published: (2018-09-01) -
Genetic testing for lymphatic malformations with or without primary lymphedema
by: Paolacci Stefano, et al.
Published: (2018-09-01) -
Étude prospective des manifestations dermatologiques des RASopathies
by: Bessis, Didier
Published: (2018) -
Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins
by: Javier-Fernando Montero-Bullón, et al.
Published: (2021-07-01)